Investigating outcomes for patients with subdural hematomas
Official title: The Subdural Hematoma Outcomes in a Population (SD HOP) Study
Funded at University of Cincinnati · NIH-11039972 · Data updated 2026-11-12
This study is looking at how people who have had subdural hematomas (a type of brain injury) do over time, especially focusing on what might cause them to go back to the hospital and how certain blood-thinning medications might affect their recovery, so that doctors can provide better care for these patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project start | March 1, 2023 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $238,905 |
| NIH project number | 5K23NS121633-03 |
| Project ID | NIH-11039972 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who have been hospitalized for subdural hematomas and are at risk for rehospitalization.
✕Less likely to help
Patients who have not experienced a subdural hematoma or those with other unrelated medical conditions may not benefit from this research.
What this research studies
This research focuses on understanding the long-term outcomes of patients who have experienced subdural hematomas (SDHs), a common cranial condition. By utilizing existing data from the Greater Cincinnati/Northern Kentucky Stroke Study, the project aims to identify factors that influence rehospitalization rates and the risks associated with antithrombotic medication use after an SDH. The study will analyze population-level data to create predictive models that can help healthcare providers better manage and follow up with SDH survivors. This research is crucial as it addresses a significant gap in knowledge regarding post-hospitalization care for these patients.
Why it matters
Potential benefit: If successful, this research could lead to improved management strategies for patients recovering from subdural hematomas, potentially reducing rehospitalization rates and enhancing overall patient outcomes.
How similar studies have gone: Other research has successfully utilized population-level data to improve outcomes in similar conditions, indicating that this approach has the potential for meaningful insights.
Where this research is happening
-
University of Cincinnati
Cincinnati, United States Active
Researchers
- Principal investigator: Robinson, David — University of Cincinnati
- Study coordinator: Robinson, David
Related research
Other NIH-funded projects on the same topics.
-
Immune and nerve signals behind acupuncture relief for sickle cell pain
This NIH grant explores how acupuncture helps reduce pain and opioid use for people with sickle cell disease.
-
MnSOD modification drives a stem-cell like switch in some ER-positive breast cancers
A small study in ER-positive breast cancer looks at how a specific mitochondrial change (MnSOD-K68 acetylation) may push cancer cells toward a more stem-like, therapy-resistant state.
-
Lineage changes in cancer cells drive resistance to radiation and hormone therapy
A cancer-focused study looks at how a mitochondrial enzyme modification may cause tumor cells to resist radiation and hormone therapy in prostate cancer.
-
Repurposed Antiretroviral Therapies to Eliminate Cervical Cancer
A pilot study tests a self-administered vaginal capsule with protease inhibitors to safely treat cervical precancer (CIN 2/3) in women, using a non-invasive approach.
-
Recombinant factor VIIa given very early for bleeding stroke
This trial gives a clotting medicine called rFVIIa very soon after a spontaneous brain bleed to adults to try to improve recovery.
-
Early Factor VIIa treatment for bleeding stroke
This project tests whether giving a clotting medicine called recombinant Factor VIIa very soon after a spontaneous brain bleed helps adults recover better than standard care alone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.